European Medical Solutions (STU:AS00) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 03, 2026)


STU:AS00 European Medical Solutions STU:AS00
51 GF Score
Price €4.70
GF Value €8.11
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions Float Percentage Of Total Shares Outstanding?

European Medical Solutions STU:AS00 -2.08% 51 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 03, 2026. GuruFocus rates STU:AS00 with a GF Score™ of 51/100 and a GF Value™ of €8.11. The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, European Medical Solutions's float shares is 0.00 Mil. European Medical Solutions's total shares outstanding is 4.23 Mil. European Medical Solutions's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, European Medical Solutions's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, European Medical Solutions's Institutional Ownership is 0.01%.

STU:AS00
51GF Score
European Medical Solutions STU:AS00
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

European Medical Solutions Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

European Medical Solutions's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/4.23
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
European Medical Solutions (STU:AS00) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 03, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on European Medical Solutions and its competitors.
Is European Medical Solutions' Float Percentage Of Total Shares Outstanding too high?
European Medical Solutions' current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, European Medical Solutions has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
European Medical Solutions' Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on European Medical Solutions and its competitors. European Medical Solutions's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current Float Percentage Of Total Shares Outstanding of 0.00%. The stock's GF Value™ is €8.11, compared to a current price of €4.70 — trading 42% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. European Medical Solutions' overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is European Medical Solutions (STU:AS00) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.70 is trading 42% below its estimated GF Value™ of €8.11.

Key valuation signals for STU:AS00:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €8.11 vs. price of €4.70 (42% below fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
51GF Score

Get the complete analysis for STU:AS00

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.70
Price
€8.11
GF Value